ETrade Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$4.74M Buy
45,627
+10,034
+28% +$1.01M 0.09% 113
2020
Q2
$3.26M Sell
35,593
-5,114
-13% -$490K 0.07% 148
2020
Q1
$3.67M Sell
40,707
-11,039
-21% -$1.17M 0.09% 115
2019
Q4
$5.87M Sell
51,746
-1,924
-4% -$211K 0.13% 94
2019
Q3
$5.83M Sell
53,670
-35,062
-40% -$3.66M 0.15% 86
2019
Q2
$8.64M Buy
88,732
+4,273
+5% +$390K 0.23% 42
2019
Q1
$7.69M Buy
84,459
+5,627
+7% +$504K 0.22% 44
2018
Q4
$7.17M Buy
78,832
+5,811
+8% +$543K 0.23% 40
2018
Q3
$7.18M Buy
73,021
+3,009
+4% +$278K 0.21% 47
2018
Q2
$5.99M Buy
70,012
+3,913
+6% +$327K 0.18% 50
2018
Q1
$5.3M Buy
66,099
+2,813
+4% +$232K 0.17% 64
2017
Q4
$5.11M Buy
63,286
+10,782
+21% +$864K 0.16% 65
2017
Q3
$4.08M Sell
52,504
-710
-1% -$58.9K 0.15% 74
2017
Q2
$4.72M Buy
53,214
+7,108
+15% +$599K 0.18% 53
2017
Q1
$3.71M Buy
46,106
+10,764
+30% +$841K 0.15% 76
2016
Q4
$2.52M Buy
35,342
+2,065
+6% +$162K 0.12% 107
2016
Q3
$2.88M Buy
33,277
+492
+2% +$42.9K 0.14% 85
2016
Q2
$2.85M Buy
32,785
+2,264
+7% +$183K 0.15% 73
2016
Q1
$2.29M Sell
30,521
-839
-3% -$63.2K 0.13% 88
2015
Q4
$2.41M Sell
31,360
-480
-2% -$36.1K 0.14% 79
2015
Q3
$2.13M Buy
31,840
+7,074
+29% +$521K 0.13% 92
2015
Q2
$1.83M Buy
24,766
+4,292
+21% +$328K 0.11% 125
2015
Q1
$1.6M Buy
+20,474
New +$1.55M 0.09% 144

Other funds holding MDT

ETrade Capital Management's MDT Position: Q3 2020 in Review

ETrade Capital Management increased its Medtronic (MDT) stake by 28% in Q3 2020, buying an estimated $1.01M and bringing the position to 45,627 shares worth $4.74M. The position accounts for 0.09% of the portfolio, ranked #113.

ETrade Capital Management first reported a position in MDT in Q1 2015 and has held it in 23 quarters since. The position peaked at $8.64M in Q2 2019. 1,811 funds tracked by Wall St. Rank hold MDT as of Q3 2020.

  • ETrade Capital Management held 45,627 shares of Medtronic worth $4.74M as of Q3 2020.
  • ETrade Capital Management bought 10,034 Medtronic shares in Q3 2020, an estimated $1.01M.
  • Medtronic made up 0.09% of ETrade Capital Management's portfolio in Q3 2020, its #113 holding.
  • ETrade Capital Management first reported a position in Medtronic in Q1 2015 and has held it in 23 quarters since.
  • ETrade Capital Management's Medtronic position peaked at $8.64M in Q2 2019.
  • 1,811 funds tracked by Wall St. Rank held Medtronic as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.